HomeOpen Access NewsHealthcare Innovation

Healthcare Innovation

Whitepaper: Emerging tech and scalable EPR: Driving NHS digital transformation in 2025

In 2025 the NHS faces a pivotal year in its digital transformation journey, guided by ambitious national policies and propelled by new technologies.

1.17 million doses of the AstraZeneca vaccine could expire in Germany

Germans have only taken 270,986 AstraZeneca doses so far, leaving roughly 1.17 million doses in storage across the country - but these shots are due to expire in less than six months.

COVID-19 and diabetes telehealth

Cecilia Van Cauwenberghe from Frost & Sullivan’s TechCasting Group, explains how the COVID-19 pandemic is the scenario for testing and demonstrating the successful implementation of diabetes telehealth platforms.

FDA reveals that Johnson & Johnson vaccine is 86% effective

New documents from the FDA show that the Johnson & Johnson vaccine appears to be 86% effective against COVID-19 - signalling that it will soon be approved in the US.

Targeted policy support for emerging biomedical innovations

Michael Morrison, Senior Researcher in Social Science at the University of Oxford, illustrates the importance of emerging biomedical innovations in the UK.

Scientists use machine learning to identify likelihood of severe COVID

The research team believe that some people have a genetic predisposition that increases likelihood of severe COVID, which may be crucial to understanding how mutations could change outcomes.

A national strategy for social care could save the NHS £1 billion every year

Research found that the supported housing and integrated mental health system could save the NHS £950 million if used as a national strategy for social care.

Science needs to overcome “structural racism” to end the HIV epidemic

A new report published in The Lancet investigates why 43% of HIV deaths in 2018 happened in the Black community, with policy solutions for the ongoing HIV epidemic.

Hong Kong approves the Sinovac COVID vaccine for use

The Sinovac COVID vaccine was revealed to be working at 50.4% efficacy by the Butantan Institute last month, but new data suggests that this could actually be 62%.

The spike mutation makes COVID eight times more infectious

The spike protein mutation found in the Brazilian, South African and UK variants of COVID-19 can make the virus eight times more infectious.

Can an mRNA vaccine be used to cure some types of cancer?

COVID brought the idea of mRNA vaccines to the attention of the world - now, cancer researchers are investigating how a similar vaccine could stop tumours in a single treatment.

Pfizer vaccine can still prevent death from the South African mutation

The Pfizer and BioNTech vaccine appears to be significantly less efficient against the South African mutation, but can still stop hosts from experiencing severe COVID and dying from the virus.

REACT study: COVID cases in hospitals “higher than at the peak of the first wave”

New data from the REACT study finds that the number of COVID cases in hospitals is higher than it was in April 2020, but that infection rates are substantially decreasing across the country.

Commission launches “HERA Incubator” project to fight COVID mutations

The European Commission today (17 February) launched the "HERA Incubator", as both a "blueprint" for long-term health emergencies and a way to stop COVID-19 mutations.

COVID-19: Surge in the use of NHS tech in 2020

Ben Davison, NHS Digital’s Executive Director for Product Development, explains how the coronavirus pandemic prompts a surge in the number of people using NHS tech in 2020.

How TECS have supported the NHS pre, during and post-COVID

Zillah Moore, Director at Tunstall Healthcare, discusses the role of technology-enabled care services and remote patient monitoring in reducing delayed discharge from hospitals and providing much-needed assistance to the NHS.

70% of available COVID vaccines in 2021 have been pre-ordered

Currently, 16% of the global population have pre-ordered 70% of available COVID vaccines in 2021 - a group of virus experts now warn that COVID will keep evolving unless low income countries can access vaccines.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders